SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 16.75
+0.25 (1.49%)
Aug 1, 2025, 4:35 PM GMT+1
SkinBioTherapeutics Employees
SkinBioTherapeutics had 15 employees as of June 30, 2024. The number of employees increased by 4 or 36.36% compared to the previous year.
Employees
15
Change (1Y)
4
Growth (1Y)
36.36%
Revenue / Employee
$178,575
Profits / Employee
-$171,685
Market Cap
43.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 15 | 4 | 36.36% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 5 | 71.43% |
| Jun 30, 2021 | 7 | 0 | - |
| Jun 30, 2020 | 7 | -1 | -12.50% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,382 |